MLH1 and colonic neoplasm: In ovarian and colon tumor xenografts that are MLH1 negative because of promoter methylation, treatment with 5-aza led to a decrease in MLH1 promoter methylation, which was associated with MLH1 expression and sensitized the xenografts to cisplatin [148].